Pdt Partners, LLC Zymeworks Inc. Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.82 - $7.7 $533,443 - $852,182	-110,673 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.0 - $16.98 $79,512 - $225,018	13,252 Added 13.6%	110,673 $725,000
Q4 2021 Feb 14, 2022	BUY	$15.19 - $29.33 $299,364 - $578,035	19,708 Added 25.36%	97,421 $1.6 Million
Q3 2021 Nov 15, 2021	BUY	$27.35 - $37.28 $572,216 - $779,972	20,922 Added 36.84%	77,713 $2.26 Million
Q2 2021 Aug 16, 2021	SELL	$26.5 - $38.23 $649,965 - $937,667	-24,527 Reduced 30.16%	56,791 $1.97 Million
Q1 2021 May 17, 2021	BUY	$29.83 - $56.81 $2.43 Million - $4.62 Million	81,318 New	81,318 $2.57 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $766M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.